INT: Afghanistan’s ‘tablet K’ – a forensic insight into an emerging synthetic drug market

Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical examiners and coroners, forensic and clinical laboratory personnel, and all other related communities about new information surrounding the emergent clandestine methamphetamine manufacturing in Afganistan.

In North America, organized criminal groups diversified their cocaine, heroin and cannabis-based business model by first adding methamphetamine and more recently fentanyl manufacture.

In Europe, an existing synthetic drug manufacture with a focus on amphetamine and MDMA diversified and expanded to also produce high potency/ purity methamphetamine in larger amounts for export, with the collaboration of Mexican cartels.

There is a potential for methamphetamine manufacture to remain a feature of the drug problem in Afghanistan and to expand, posing a health threat for the population both in the country and beyond. In view of this, clandestine manufacture of methamphetamine in Afghanistan should receive an equal amount of attention as heroin production.

Read Full Report Here

Tags: Opioid Crisis

National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913

Copyright © 2024 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy

Log in with your credentials


Forgot your details?

Create Account